Your browser doesn't support javascript.
loading
The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study.
Nie, Xiaoyan; Wang, Ruilin; Liang, Guangkai; Zhang, Xinyi; Tang, Ningjia; Cai, Yuchun; Han, Congxiao; Zhao, Yuxuan; Jia, Tong; Zhang, Fang; Han, Sheng; Guan, Xiaodong; Shi, Luwen; Lu, Christine Y.
Afiliação
  • Nie X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Wang R; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Liang G; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Zhang X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Tang N; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Cai Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Han C; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Zhao Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Jia T; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Zhang F; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Han S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Guan X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Shi L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Lu CY; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Int J Health Policy Manag ; 12: 7343, 2023.
Article em En | MEDLINE | ID: mdl-37579366
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Gastos em Saúde / Inibidores da Bomba de Prótons Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Health Policy Manag Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Gastos em Saúde / Inibidores da Bomba de Prótons Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Health Policy Manag Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China